| Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma MJ Borad, MD Champion, JB Egan, WS Liang, R Fonseca, AH Bryce, ... PLoS genetics 10 (2), e1004135, 2014 | 360 | 2014 |
| Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma YX Zhu, E Braggio, CX Shi, KM Kortuem, LA Bruins, JE Schmidt, ... Blood, The Journal of the American Society of Hematology 124 (4), 536-545, 2014 | 243 | 2014 |
| Comparative genomic analysis of human fungal pathogens causing paracoccidioidomycosis CA Desjardins, MD Champion, JW Holder, A Muszewska, J Goldberg, ... PLoS genetics 7 (10), e1002345, 2011 | 204 | 2011 |
| Comparative Genomic Characterization of Francisella tularensis Strains Belonging to Low and High Virulence Subspecies MD Champion, Q Zeng, EB Nix, FE Nano, P Keim, CD Kodira, ... PLoS pathogens 5 (5), e1000459, 2009 | 161 | 2009 |
| IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism D Yamada, S Rizvi, N Razumilava, SF Bronk, JI Davila, MD Champion, ... Hepatology 61 (5), 1627-1642, 2015 | 138 | 2015 |
| The clinical significance of cereblon expression in multiple myeloma SR Schuster, KM Kortuem, YX Zhu, E Braggio, CX Shi, LA Bruins, ... Leukemia research 38 (1), 23-28, 2014 | 132 | 2014 |
| High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma TH Ho, IY Park, H Zhao, P Tong, MD Champion, H Yan, FA Monzon, ... Oncogene 35 (12), 1565-1574, 2016 | 89 | 2016 |
| Playing for half the deck: the molecular biology of meiosis MD Champion, RS Hawley Nature Medicine 8 (Suppl 10), S50-S56, 2002 | 84 | 2002 |
| Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in ‐17p high risk disease KM Kortüm, C Langer, J Monge, L Bruins, JB Egan, YX Zhu, CX Shi, ... British journal of haematology 168 (4), 507-510, 2015 | 63 | 2015 |
| When Outgroups Fail; Phylogenomics of Rooting the Emerging Pathogen, Coxiella burnetii T Pearson, HM Hornstra, JW Sahl, S Schaack, JM Schupp, ... Systematic biology 62 (5), 752-762, 2013 | 56 | 2013 |
| Phylogeography of Francisella tularensis subspecies holarctica from the country of Georgia G Chanturia, DN Birdsell, M Kekelidze, E Zhgenti, G Babuadze, ... BMC microbiology 11, 1-10, 2011 | 47 | 2011 |
| A Deficiency Screen of the Major Autosomes Identifies a Gene (matrimony) That Is Haplo-insufficient for Achiasmate Segregation in Drosophila Oocytes D Harris, C Orme, J Kramer, L Namba, M Champion, MJ Palladino, ... Genetics 165 (2), 637-652, 2003 | 45 | 2003 |
| Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements JB Egan, MT Barrett, MD Champion, S Middha, E Lenkiewicz, L Evers, ... PloS one 9 (2), e87113, 2014 | 27 | 2014 |
| RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2 YX Zhu, H Yin, LA Bruins, CX Shi, P Jedlowski, M Aziz, C Sereduk, ... Blood, The Journal of the American Society of Hematology 125 (3), 483-491, 2015 | 25 | 2015 |
| Clinical implementation of integrated genomic profiling in patients with advanced cancers MJ Borad, JB Egan, RM Condjella, WS Liang, R Fonseca, NR Ritacca, ... Scientific reports 6 (1), 25, 2016 | 22 | 2016 |
| Host-pathogen o-methyltransferase similarity and its specific presence in highly virulent strains of Francisella tularensis suggests molecular mimicry MD Champion PloS one 6 (5), e20295, 2011 | 14 | 2011 |
| A multidisciplinary biospecimen bank of renal cell carcinomas compatible with discovery platforms at Mayo Clinic, Scottsdale, Arizona TH Ho, RN Nateras, H Yan, JG Park, S Jensen, C Borges, JH Lee, ... PloS one 10 (7), e0132831, 2015 | 13 | 2015 |
| The Evolutionary History of Amino Acid Variations Mediating Increased Resistance of S. aureus Identifies Reversion Mutations in Metabolic Regulators MD Champion, V Gray, C Eberhard, S Kumar Plos one 8 (2), e56466, 2013 | 5 | 2013 |
| Development and results of a multiple myeloma specific custom 77-gene mutation panel for clinical targeted sequencing KM Kortuem, AK Stewart, LA Bruins, G Ahmann, G Vasmatzis, ... Blood 124 (21), 169, 2014 | 3 | 2014 |
| Identification of cereblon binding proteins and relationship with response and survival following pomalidomide and dexamethasone in multiple myeloma YX Zhu, E Braggio, CX Shi, KM Kortuem, LA Bruins, JE Schmidt, ... Blood 124 (4), 536-45, 2014 | 3 | 2014 |
Mitesh J. BoradMayo Clinic在 mayo.edu 的电子邮件经过验证
